O'Donnell DE - Search Results

1

Diagnosis, assessment, and phenotyping of COPD: beyond FEV₁.

Lange P, Halpin DM, O'Donnell DE, MacNee W. Lange P, et al. Int J Chron Obstruct Pulmon Dis. 2016 Feb 19;11 Spec Iss(Spec Iss):3-12. doi: 10.2147/COPD.S85976. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 26937185 Free PMC article. Review.

2

Effect of obesity on respiratory mechanics during rest and exercise in COPD.

Ora J, Laveneziana P, Wadell K, Preston M, Webb KA, O'Donnell DE. Ora J, et al. J Appl Physiol (1985). 2011 Jul;111(1):10-9. doi: 10.1152/japplphysiol.01131.2010. Epub 2011 Feb 24. J Appl Physiol (1985). 2011. PMID: 21350021 Free article.

3

Recent advances in pharmacotherapy for dyspnea in COPD.

Raghavan N, Webb K, Amornputtisathaporn N, O'Donnell DE. Raghavan N, et al. Curr Opin Pharmacol. 2011 Jun;11(3):204-10. doi: 10.1016/j.coph.2011.03.002. Epub 2011 Mar 28. Curr Opin Pharmacol. 2011. PMID: 21450522 Review.

4

Sex differences in exertional dyspnea in patients with mild COPD: physiological mechanisms.

Guenette JA, Jensen D, Webb KA, Ofir D, Raghavan N, O'Donnell DE. Guenette JA, et al. Respir Physiol Neurobiol. 2011 Aug 15;177(3):218-27. doi: 10.1016/j.resp.2011.04.011. Epub 2011 Apr 16. Respir Physiol Neurobiol. 2011. PMID: 21524719

5

Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD.

Guenette JA, Raghavan N, Harris-McAllister V, Preston ME, Webb KA, O'Donnell DE. Guenette JA, et al. Respir Med. 2011 Dec;105(12):1836-45. doi: 10.1016/j.rmed.2011.08.021. Epub 2011 Sep 13. Respir Med. 2011. PMID: 21917440 Free article. Clinical Trial.

6

Does dynamic hyperinflation contribute to dyspnoea during exercise in patients with COPD?

Guenette JA, Webb KA, O'Donnell DE. Guenette JA, et al. Eur Respir J. 2012 Aug;40(2):322-9. doi: 10.1183/09031936.00157711. Epub 2011 Dec 19. Eur Respir J. 2012. PMID: 22183485 Free article.

7

Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample.

Raghavan N, Lam YM, Webb KA, Guenette JA, Amornputtisathaporn N, Raghavan R, Tan WC, Bourbeau J, O'Donnell DE. Raghavan N, et al. COPD. 2012 Apr;9(2):175-83. doi: 10.3109/15412555.2011.650802. Epub 2012 Mar 12. COPD. 2012. PMID: 22409441

8

Effect of fluticasone/salmeterol combination on dyspnea and respiratory mechanics in mild-to-moderate COPD.

Guenette JA, Webb KA, O'Donnell DE. Guenette JA, et al. Respir Med. 2013 May;107(5):708-16. doi: 10.1016/j.rmed.2013.01.009. Epub 2013 Feb 17. Respir Med. 2013. PMID: 23421968 Free article. Clinical Trial.

9

Impact of pulmonary rehabilitation on the major dimensions of dyspnea in COPD.

Wadell K, Webb KA, Preston ME, Amornputtisathaporn N, Samis L, Patelli J, Guenette JA, O'Donnell DE. Wadell K, et al. COPD. 2013 Aug;10(4):425-35. doi: 10.3109/15412555.2012.758696. Epub 2013 Mar 28. COPD. 2013. PMID: 23537344 Clinical Trial.

10

Should mild COPD be treated? Evidence for early pharmacological intervention.

Elbehairy AF, Webb KA, Neder JA, O'Donnell DE. Elbehairy AF, et al. Drugs. 2013 Dec;73(18):1991-2001. doi: 10.1007/s40265-013-0145-9. Drugs. 2013. PMID: 24214364 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page